These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23315371)

  • 41. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study.
    Cascino TM; Colvin MM; Lanfear DE; Richards B; Khalatbari S; Mann DL; Taddei-Peters WC; Jeffries N; Watkins DC; Stewart GC; Aaronson KD;
    Circ Heart Fail; 2023 Jan; 16(1):e009745. PubMed ID: 36259388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A retrospective study of left ventricular assist device-related infections.
    Bentz B; Hupcey JE; Polomano RC; Boehmer JP
    J Cardiovasc Manag; 2004; 15(1):9-16. PubMed ID: 14976692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Driveline Site Is Not a Predictor of Infection After Ventricular Assist Device Implantation.
    Martin BJ; Luc JGY; Maruyama M; MacArthur R; Bates AR; Buchholz H; Freed DH; Conway J
    ASAIO J; 2018; 64(5):616-622. PubMed ID: 29035899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
    Héquet D; Kralidis G; Carrel T; Cusini A; Garzoni C; Hullin R; Meylan PR; Mohacsi P; Mueller NJ; Ruschitzka F; Tozzi P; van Delden C; Weisser M; Wilhelm MJ; Pascual M; Manuel O;
    BMC Infect Dis; 2016 Jul; 16():321. PubMed ID: 27391967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation.
    Bhatia N; Voelkel AJ; Hussain Z; Sharma UC; Slaughter MS; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):675-83. PubMed ID: 26366889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures.
    Milano C; Pagani FD; Slaughter MS; Pham DT; Hathaway DR; Jacoski MV; Najarian KB; Aaronson KD;
    Circulation; 2014 Sep; 130(11 Suppl 1):S3-11. PubMed ID: 25200052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device.
    John R; Aaronson KD; Pae WE; Acker MA; Hathaway DR; Najarian KB; Slaughter MS;
    J Heart Lung Transplant; 2014 Oct; 33(10):1066-73. PubMed ID: 25087103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ventricular assist devices as a bridge to cardiac transplantation. A prelude to destination therapy.
    Holman WL; Bourge RC; Spruell RD; Murrah CP; McGiffin DC; Kirklin JK
    Ann Surg; 1997 Jun; 225(6):695-704; discussion 705-6. PubMed ID: 9230810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Left ventricular assist device-related infections: a multicentric study.
    Siméon S; Flécher E; Revest M; Niculescu M; Roussel JC; Michel M; Leprince P; Tattevin P
    Clin Microbiol Infect; 2017 Oct; 23(10):748-751. PubMed ID: 28323195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of left ventricular assist device driveline infection: A systematic literature review.
    Pavlovic NV; Randell T; Madeira T; Hsu S; Zinoviev R; Abshire M
    Heart Lung; 2019; 48(2):90-104. PubMed ID: 30573195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infections in Patients With Left Ventricular Assist Devices: Current State and Future Perspectives.
    Inglis SS; Suh GA; Razonable RR; Schettle SD; Spencer PJ; Villavicencio MA; Rosenbaum AN
    ASAIO J; 2023 Jul; 69(7):633-641. PubMed ID: 37145863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of ventricular assist device placement on longitudinal renal function in children with end-stage heart failure.
    May LJ; Montez-Rath ME; Yeh J; Axelrod DM; Chen S; Maeda K; Almond CS; Rosenthal DN; Hollander SA; Sutherland SM
    J Heart Lung Transplant; 2016 Apr; 35(4):449-56. PubMed ID: 26653933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries.
    Michel E; Orozco Hernandez E; Enter D; Monge M; Nakano J; Rich J; Anderson A; Backer C; McCarthy P; Pham D
    Artif Organs; 2019 Jan; 43(1):90-96. PubMed ID: 30129258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
    Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ten-year retrospective cohort analysis of ventricular assist device infections.
    Spano G; Buffle E; Walti LN; Mihalj M; Cameron DR; Martinelli M; Fürholz M; Que YA; Hayward C; Reineke D; Hunziker L; Schnegg B
    Artif Organs; 2023 May; 47(5):898-905. PubMed ID: 36478260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
    Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of end-stage heart disease with outpatient ventricular assist devices.
    Holman WL; Davies JE; Rayburn BK; McGiffin DC; Foley BA; Benza RL; Bourge RC; Blood P; Kirklin JK
    Ann Thorac Surg; 2002 May; 73(5):1489-93; discussion 1493-4. PubMed ID: 12022538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections.
    Arrecubieta C; Toba FA; von Bayern M; Akashi H; Deng MC; Naka Y; Lowy FD
    PLoS Pathog; 2009 May; 5(5):e1000411. PubMed ID: 19412528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.